Katherine E Goodman

1.9k total citations · 1 hit paper
50 papers, 1.3k citations indexed

About

Katherine E Goodman is a scholar working on Applied Microbiology and Biotechnology, Epidemiology and Infectious Diseases. According to data from OpenAlex, Katherine E Goodman has authored 50 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Applied Microbiology and Biotechnology, 16 papers in Epidemiology and 10 papers in Infectious Diseases. Recurrent topics in Katherine E Goodman's work include Antibiotic Use and Resistance (21 papers), Antibiotic Resistance in Bacteria (9 papers) and Urinary Tract Infections Management (9 papers). Katherine E Goodman is often cited by papers focused on Antibiotic Use and Resistance (21 papers), Antibiotic Resistance in Bacteria (9 papers) and Urinary Tract Infections Management (9 papers). Katherine E Goodman collaborates with scholars based in United States, Canada and Nigeria. Katherine E Goodman's co-authors include Justin Lessler, Joshua Kaminsky, Qifang Bi, Pranita D. Tamma, Anthony Harris, Patricia J. Simner, Tsigereda Tekle, Anthony D. Harris, Aaron M. Milstone and Sara E. Cosgrove and has published in prestigious journals such as New England Journal of Medicine, JAMA and SHILAP Revista de lepidopterología.

In The Last Decade

Katherine E Goodman

47 papers receiving 1.3k citations

Hit Papers

What is Machine Learning? A Primer for the Epidemiologist 2019 2026 2021 2023 2019 100 200 300
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. What is Machine Learning? A Primer for the Epidemiologist
    2019 342 citations Katherine E Goodman, Justin Lessler et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katherine E Goodman United States 17 461 315 289 260 171 50 1.3k
Gabriel Birgand France 22 340 0.7× 442 1.4× 321 1.1× 192 0.7× 365 2.1× 99 1.8k
Gaetano Pierpaolo Privitera Italy 28 249 0.5× 158 0.5× 528 1.8× 208 0.8× 664 3.9× 123 2.8k
Makoto Jones United States 27 316 0.7× 743 2.4× 890 3.1× 440 1.7× 774 4.5× 145 2.2k
Cristina Vazquez Guillamet United States 19 277 0.6× 257 0.8× 515 1.8× 192 0.7× 199 1.2× 40 1.2k
Miguel Sánchez García Spain 20 324 0.7× 183 0.6× 468 1.6× 232 0.9× 439 2.6× 55 1.8k
Prabasaj Paul United States 18 342 0.7× 224 0.7× 302 1.0× 121 0.5× 570 3.3× 51 2.0k
Anthony Harris United States 20 581 1.3× 421 1.3× 595 2.1× 255 1.0× 298 1.7× 36 2.3k
María Bodi Spain 22 322 0.7× 114 0.4× 917 3.2× 46 0.2× 224 1.3× 89 2.1k
Payal Patel United States 21 161 0.3× 435 1.4× 535 1.9× 85 0.3× 527 3.1× 105 1.7k
Saad Alhumaid Saudi Arabia 25 179 0.4× 248 0.8× 322 1.1× 75 0.3× 1.1k 6.6× 77 2.2k

Countries citing papers authored by Katherine E Goodman

Since Specialization
Citations

This map shows the geographic impact of Katherine E Goodman's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katherine E Goodman with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katherine E Goodman more than expected).

Fields of papers citing papers by Katherine E Goodman

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katherine E Goodman. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katherine E Goodman. The network helps show where Katherine E Goodman may publish in the future.

Co-authorship network of co-authors of Katherine E Goodman

This figure shows the co-authorship network connecting the top 25 collaborators of Katherine E Goodman. A scholar is included among the top collaborators of Katherine E Goodman based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katherine E Goodman. Katherine E Goodman is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Goodman, Katherine E & Daniel J. Morgan. (2025). Digital Exhaust or Digital Gold? The Value of AI-Generated Clinical Visit Transcripts. New England Journal of Medicine. 394(2). 110–113.
2.
Harris, Anthony D., Katherine E Goodman, Lisa Pineles, et al.. (2025). New Kids on the Block: Estimating Use of Next-generation Gram-negative Antibiotics Across Greater Than 700 Hospitals in the United States. Open Forum Infectious Diseases. 12(2). ofaf079–ofaf079. 1 indexed citations
3.
Goodman, Katherine E, et al.. (2025). Generative Artificial Intelligence–based Surveillance for Avian Influenza Across a Statewide Healthcare System. Clinical Infectious Diseases. 81(5). 900–903. 2 indexed citations
4.
Baghdadi, Jonathan, Katherine E Goodman, Laurence S. Magder, et al.. (2025). Association Between Delayed Broad-Spectrum Gram-negative Antibiotics and Clinical Outcomes: How Much Does Getting It Right With Empiric Antibiotics Matter?. Clinical Infectious Diseases. 80(5). 949–958. 3 indexed citations
5.
Goodman, Katherine E, Westyn Branch‐Elliman, Erica S. Shenoy, et al.. (2025). Using Generative Artificial Intelligence for Healthcare-Associated Infection Surveillance. Clinical Infectious Diseases. 82(3). 473–479.
6.
7.
Rodríguez-Nava, Guillermo, et al.. (2024). Performance of a large language model for identifying central line-associated bloodstream infections (CLABSI) using real clinical notes. Infection Control and Hospital Epidemiology. 46(3). 305–308. 5 indexed citations
8.
Goodman, Katherine E, Monica Taneja, Eili Klein, et al.. (2024). A multi-center validation of the electronic health record admission source and discharge location fields against the clinical notes for identifying inpatients with long-term care facility exposure. Infection Control and Hospital Epidemiology. 45(8). 979–984. 1 indexed citations
9.
Cabral, Stephanie, Anthony Harris, Sara E. Cosgrove, et al.. (2023). Adherence to Antimicrobial Prophylaxis Guidelines for Elective Surgeries Across 825 US Hospitals, 2019–2020. Clinical Infectious Diseases. 76(12). 2106–2115. 10 indexed citations
10.
Baghdadi, Jonathan, Katherine E Goodman, Laurence S. Magder, et al.. (2023). Clinical, contextual and hospital-level factors associated with escalation and de-escalation of empiric Gram-negative antibiotics among US inpatients. JAC-Antimicrobial Resistance. 5(3). dlad054–dlad054. 2 indexed citations
11.
Nadimpalli, Gita, Lyndsay M. O’Hara, Laurence S. Magder, et al.. (2022). Comorbidities associated with 30-day readmission following index coronavirus disease 2019 (COVID-19) hospitalization: A retrospective cohort study of 331,136 patients in the United States. Infection Control and Hospital Epidemiology. 44(8). 1325–1333. 5 indexed citations
12.
Goodman, Katherine E, Emily L. Heil, Kimberly C. Claeys, Mary Banoub, & Jacqueline Bork. (2022). Real-world Antimicrobial Stewardship Experience in a Large Academic Medical Center: Using Statistical and Machine Learning Approaches to Identify Intervention “Hotspots” in an Antibiotic Audit and Feedback Program. Open Forum Infectious Diseases. 9(7). ofac289–ofac289. 16 indexed citations
13.
Goodman, Katherine E, Jonathan Baghdadi, Laurence S. Magder, et al.. (2022). Patterns, Predictors, and Intercenter Variability in Empiric Gram-Negative Antibiotic Use Across 928 United States Hospitals. Clinical Infectious Diseases. 76(3). e1224–e1235. 17 indexed citations
14.
Pineles, Beth L., Katherine E Goodman, Lisa Pineles, et al.. (2021). In-Hospital Mortality in a Cohort of Hospitalized Pregnant and Nonpregnant Patients With COVID-19. Annals of Internal Medicine. 174(8). 1186–1188. 18 indexed citations
15.
Goodman, Katherine E, Lisa Pineles, Laurence S. Magder, et al.. (2020). Electronically Available Patient Claims Data Improve Models for Comparing Antibiotic Use Across Hospitals: Results From 576 US Facilities. Clinical Infectious Diseases. 73(11). e4484–e4492. 14 indexed citations
16.
Goodman, Katherine E, Laurence S. Magder, Jonathan Baghdadi, et al.. (2020). Impact of Sex and Metabolic Comorbidities on Coronavirus Disease 2019 (COVID-19) Mortality Risk Across Age Groups: 66 646 Inpatients Across 613 U.S. Hospitals. Clinical Infectious Diseases. 73(11). e4113–e4123. 60 indexed citations
17.
Goodman, Katherine E, Sara E. Cosgrove, Lisa Pineles, et al.. (2020). Significant Regional Differences in Antibiotic Use Across 576 US Hospitals and 11 701 326 Adult Admissions, 2016–2017. Clinical Infectious Diseases. 73(2). 213–222. 34 indexed citations
18.
Goodman, Katherine E, Justin Lessler, Anthony D. Harris, Aaron M. Milstone, & Pranita D. Tamma. (2019). A methodological comparison of risk scores versus decision trees for predicting drug-resistant infections: A case study using extended-spectrum beta-lactamase (ESBL) bacteremia. Infection Control and Hospital Epidemiology. 40(4). 400–407. 32 indexed citations
19.
Goodman, Katherine E, Patricia J. Simner, Eili Klein, et al.. (2019). Predicting probability of perirectal colonization with carbapenem-resistant Enterobacteriaceae (CRE) and other carbapenem-resistant organisms (CROs) at hospital unit admission. Infection Control and Hospital Epidemiology. 40(5). 541–550. 33 indexed citations
20.
Goodman, Katherine E, Patricia J. Simner, Eili Klein, et al.. (2018). How frequently are hospitalized patients colonized with carbapenem-resistant Enterobacteriaceae (CRE) already on contact precautions for other indications?. Infection Control and Hospital Epidemiology. 39(12). 1491–1493. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Gabriel Birgand Breakdown of academic impact, for papers by Gaetano Pierpaolo Privitera Breakdown of academic impact, for papers by Makoto Jones Breakdown of academic impact, for papers by Cristina Vazquez Guillamet Breakdown of academic impact, for papers by Miguel Sánchez García Breakdown of academic impact, for papers by Prabasaj Paul Breakdown of academic impact, for papers by Anthony Harris Breakdown of academic impact, for papers by María Bodi Breakdown of academic impact, for papers by Payal Patel Breakdown of academic impact, for papers by Saad Alhumaid
Rankless by CCL
2026